Simvastatin Improves Inflammation, Platelet Activation Markers in Primary Hypercholesterolemia

In patients with primary hypercholesterolemia, short-term treatment with simvastatin improved the lipid profile and exerted a beneficial effect on a wide range of proatherogenic and prothrombotic parameters.

Source link

Related posts

RESPONSE: Embracing the Gap Year as a Hospitalist


Exercise may help people with cardiovascular disease the most


Transcatheter Mitral Valve Replacement: The End of the Beginning?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World